Experienced in AIDS Dementia Complex

Rahul S. Kulkarni

Pune, MH, IN 
Clinical Trials:Currently Recruiting for 2 Trials
Experienced in AIDS Dementia Complex
Pune, MH, IN 
OverviewLocationsClinical Research

Overview

Rahul Kulkarni practices in Pune, India. Mr. Kulkarni is rated as an Experienced expert by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are Mucormycosis, COVID-19, Guillain-Barre Syndrome, and Stroke.

His clinical research consists of co-authoring 28 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of AIDS Dementia Complex.

Gender
Male

Locations

Pune, MH, India
Other Locations
Mumbai, MH, India
Nagpur, MH, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Galcanezumab in Patients With Episodic Migraine-the Persist Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Galcanezumab in Patients With Episodic Migraine-the Persist Study
Enrollment Status: Completed
Publish Date: March 28, 2023
Intervention Type: Drug
Study Drug: Galcanezumab
Study Phase: Phase 3
Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
View 2 Less Clinical Trial

28 Total Publications

Narketpally Syndrome and the Embedding of Contextual Values in Real-Life Patient Pathways.
Narketpally Syndrome and the Embedding of Contextual Values in Real-Life Patient Pathways.
Journal: Journal of evaluation in clinical practice
Published: May 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kulkarni's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile